title: Consensus evidence-based guidelines for insulin therapy in patients with type 1 diabetes mellitus as per Indian clinical practice.
abstract: Type 1 diabetes mellitus (T1DM) is a chronic disease characterised by auto-immune destruction of insulin producing beta cells of the pancreas. Most cases of T1DM are diagnosed during childhood and adolescence, and it remains the predominant form of the disease in this population. Early identification and treatment of T1DM is important in reducing complications of this form of disease. Because individuals with T1DM lack endogenous insulin production, the current consensus guideline recommends administration of rapid-acting and long-acting analogues for all patients with T1DM to achieve glycaemic goals and reduce insulin-induced side effects like weight gain and hypoglycaemia. It also emphasises that effective use of insulin requires an understanding of various insulin treatment and regimens, sick-day management regarding insulin use, and ability to manage insulin-induced hypoglycaemia to achieve the individualised treatment goals established between the patient, family and diabetes care team. The current consensus guideline has been developed by a panel of experts based on the existing guidelines which aims to provide better clinical practice in the Indian scenario for the management of T1DM.
authors: Alok
authors: A
authors: Kanungo
authors: Ashok
authors: A
authors: Jhingan
authors: Rakesh Kumar
authors: RK
authors: Sahay
authors: A
authors: A
authors: Muruganathan
authors: Ashok Kumar
authors: AK
authors: Das
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007194:India; D007328:Insulin / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin